Company / EPS (Diluted)
Revvity EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$5.55
FY2025
5-year range
$2.04 / $8.08
FY2021-FY2025
Trend
+23.3%
vs FY2024
Sector context
#29 of 159
Health Care
What the data says
Revvity's eps (diluted) of $5.55 is higher than 82% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 10 years, ranging from $1.39 in FY2016 to $8.08 in FY2023.
Based on SEC 10-K filings.
5.55 in FY2025 with a 5-year CAGR of +21.1%. Top quartile in the Health Care sector.
Declined from $8.08 to $5.55 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -5.1%
- 5-Year CAGR
- +21.1%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 159This company $5.55 Sector average $1.56
▼
+256.5% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 23.3% year-over-year.
- Ranks #29 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2016.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.55 | +23.3% |
| FY2024 | $4.50 | -44.3% |
| FY2023 | $8.08 | +24.5% |
| FY2022 | $6.49 | +218.1% |
| FY2021 | $2.04 | -4.2% |
| FY2020 | $2.13 | -19.3% |
| FY2019 | $2.64 | +24.5% |
| FY2018 | $2.12 | +13.4% |
| FY2017 | $1.87 | +34.5% |
| FY2016 | $1.39 | -5.4% |
As of FY2025 · SEC 10-K · Updated Mar 14, 2026